Seagen Appoints David Epstein As New CEO

RTTNews | 980天前
Seagen Appoints David Epstein As New CEO

(RTTNews) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world.

He then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. More recently, he was executive partner at Flagship Pioneering.

In addition, Seagen announced that Roger Dansey, M.D., who has served as Seagen's Chief Medical Officer (CMO) since 2018 and as Interim CEO since May 2022, has been appointed President, Research and Development.

In this new role, Dansey will continue to serve as CMO reporting to Epstein.

read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 581天前
Malaysia GDP Data Due On Friday

Malaysia GDP Data Due On Friday

Malaysia will on Friday release preliminary Q2 numbers for gross domestic product, highlighting a light day for Asia-Pacific economic activity. In the first quarter, GDP was up 4.4 percent on year.
RTTNews | 23分鐘前
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

The Switzerland market closed on a firm note on Thursday, in line with markets across Europe, amid hopes the European Union and the U.S. will agree on a trade deal before the deadline. Positive reacting to some earnings updates also contributed to market's higher close.
RTTNews | 4小時18分鐘前